Literature DB >> 28169866

Low-Grade Neuroendocrine Carcinoma of the Skin (Primary Cutaneous Carcinoid Tumor) as a Distinctive Entity of Cutaneous Neuroendocrine Tumors: A Clinicopathologic Study of 3 Cases With Literature Review.

Keisuke Goto1, Takashi Anan, Takashi Nakatsuka, Yo Kaku, Takaki Sakurai, Takaya Fukumoto, Tetsunori Kimura, Arihiro Shibata.   

Abstract

There is scarcity of information on primary cutaneous low-grade neoplasms commonly known as carcinoid tumors, owing to their rarity. The authors present 3 cases that were named "low-grade neuroendocrine carcinoma of the skin" (LGNECS). These occurred in the dermis and subcutis of the anterior chest or the inguinal region in the elderly. Histologically, the tumors showed infiltrating proliferation of nests of various sizes, with low-grade neuroendocrine cytologic features but without mucin production. All cases exhibited varying degrees of intraductal tumor components. On immunohistochemical examination, these tumors expressed estrogen receptor alpha, progesterone receptor, androgen receptor, gross cystic disease fluid protein 15, mammaglobin, and GATA3 as well as neuroendocrine markers. Although a literature review revealed 8 additional possible cases with no evidence of other diseases, it was difficult to determine if these were true cases of LGNECS, because of the limited information available. Based on its characteristic histologic features and immunoprofile, it can be proposed designating LGNECS as a distinct entity among cutaneous neuroendocrine tumors. Otherwise, such tumors could be misdiagnosed as mammary carcinomas (particularly when involving the skin of the breast) or as metastatic visceral neuroendocrine tumors of the skin.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28169866     DOI: 10.1097/DAD.0000000000000657

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  4 in total

1.  Sweat-gland carcinoma with neuroendocrine differentiation (SCAND): a clinicopathologic study of 13 cases with genetic analysis.

Authors:  Keisuke Goto; Yoji Kukita; Keiichiro Honma; Nobuyuki Ohike; Takaya Komori; Yoshihiro Ishida; Misawo Ishikawa; Takashi Nakatsuka; Soichi Fumita; Koichi Nakagawa; Aya Okabayashi; Yoshifumi Iwahashi; Tomoyuki Tanino; Keisuke Kikuchi; Yoshie Kawahara; Tsunekazu Hishima; Jiro Uehara; Takuma Oishi; Taiki Isei
Journal:  Mod Pathol       Date:  2021-09-12       Impact factor: 7.842

2.  Investigation of the RB1-SOX2 axis constitutes a tool for viral status determination and diagnosis in Merkel cell carcinoma.

Authors:  Soumanth Thanguturi; Anne Tallet; Elodie Miquelestorena-Standley; Catherine Coco; Yannick Le Corre; Ewa Hainaut-Wierzbicka; Astrid Blom; Philippe Saiag; Nathalie Beneton; Guido Bens; Julia Zaragoza; Charlee Nardin; François Aubin; Monica Dinulescu; Marie-Christine Machet; Roland Houben; David Schrama; Christine Collin; Gaëlle Fromont; Marie-Laure Jullie; Nicolas Macagno; Pauline Gaboriaud; Patricia Berthon; Antoine Touzé; Serge Guyétant; Mahtab Samimi; Thibault Kervarrec
Journal:  Virchows Arch       Date:  2022-04-12       Impact factor: 4.064

Review 3.  Recent Advances on Immunohistochemistry and Molecular Biology for the Diagnosis of Adnexal Sweat Gland Tumors.

Authors:  Nicolas Macagno; Pierre Sohier; Thibault Kervarrec; Daniel Pissaloux; Marie-Laure Jullie; Bernard Cribier; Maxime Battistella
Journal:  Cancers (Basel)       Date:  2022-01-18       Impact factor: 6.639

4.  A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

Authors:  Guido Rindi; David S Klimstra; Behnoush Abedi-Ardekani; Sylvia L Asa; Frederik T Bosman; Elisabeth Brambilla; Klaus J Busam; Ronald R de Krijger; Manfred Dietel; Adel K El-Naggar; Lynnette Fernandez-Cuesta; Günter Klöppel; W Glenn McCluggage; Holger Moch; Hiroko Ohgaki; Emad A Rakha; Nicholas S Reed; Brian A Rous; Hironobu Sasano; Aldo Scarpa; Jean-Yves Scoazec; William D Travis; Giovanni Tallini; Jacqueline Trouillas; J Han van Krieken; Ian A Cree
Journal:  Mod Pathol       Date:  2018-08-23       Impact factor: 7.842

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.